Overview


According to FutureWise analysis, the market for Neuroplasticity is expected to grow with a CAGR of 27.42% over the forecast period 2024-2032, and reach a market value of US$ 45.8 Billion by 2031. 

Neuroplasticity, also known as brain plasticity, is a remarkable adaptive property of the brain that allows it to reorganize and rewire its structure, function, and connections in response to experiences, learning, and environmental influences. This dynamic process is crucial for the brain's ability to adapt to new information, recover from injuries, and develop and refine skills over time.

At the core of neuroplasticity is the brain's capacity to form and strengthen synaptic connections between neurons. Neurons serve as the basic units of the nervous system, facilitating communication through specialized connections known as synapses. When neurons are frequently activated together, the synapses between them become more robust, facilitating more efficient and effective communication. Neuroplasticity is most prominent during critical periods of development, such as early childhood, when the brain is highly adaptable and responsive to environmental stimuli. However, it persists throughout life to varying degrees, allowing for ongoing learning, adaptation, and recovery. Various factors influence the extent and effectiveness of neuroplasticity, including age, genetics, the type and intensity of experiences, and the presence of neurological conditions. Additionally, activities that engage the brain in challenging and stimulating ways, such as learning a new skill, playing musical instruments, or engaging in cognitive exercises, can enhance and harness the potential of neuroplasticity.

FutureWise Market Research has published a report that provides an insightful analysis of Neuroplasticity Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts' projects that the Neuroplasticity Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • NeuroSky Inc.
  • Posit Science Corporation
  • BrainHQ
  • Synaptitude Brain Health
  • Mindmaze SA
  • NeuroVigil Inc.
  • Lumosity
  • Neuronetics, Inc.
  • CogniFit
  • Advanced Brain Monitoring
  • SharpBrains
  • Emotiv Inc.
  • BrainCo
  • Neuroscape
  • Neuroplast BV
  • Reha Technology AG
  • Virtualware Group
  • Nexeon Medsystems Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Neuroplasticity Market:

  • In 2022, the FDA approved the BIONIK Mindgate N2, a brain-computer interface (BCI) device designed to empower individuals with paralysis in operating prosthetic limbs and other assistive equipment.

Ongoing developments in neuroscience, including advanced brain imaging technologies like fMRI and PET scans, are expanding our understanding of neuroplasticity. This is driving research and innovation in neuroplasticity-based interventions and therapies. The rising occurrence of neurological disorders like stroke, traumatic brain injuries, and neurodegenerative diseases has spurred a need for neurorehabilitation and interventions centered around neuroplasticity. These aim to elevate recovery outcomes and enhance overall quality of life. Globally, the senior population is increasing, and there is a greater need for interventions to address age-related cognitive decline and promote healthy brain aging. Neuroplasticity-based approaches offer potential solutions to maintain cognitive function and delay cognitive decline. Advances in technology, including virtual reality (VR), robotics, and neurofeedback systems, enable more sophisticated and effective neurorehabilitation interventions. These technologies harness the principles of neuroplasticity to enhance recovery outcomes and bolsters the market growth.

Implementing neuroplasticity-based interventions often requires specialized training and expertise. This complexity can limit widespread adoption and accessibility, particularly in regions with limited healthcare resources. Developing and deploying neuroplasticity interventions may be subject to regulatory scrutiny and ethical considerations, particularly when involving advanced technologies or experimental procedures. Access to cutting-edge technologies in neuroplasticity interventions, such as high-end neuroimaging equipment or advanced rehabilitation devices, may be cost-prohibitive for some healthcare facilities or individuals, hampers the market growth.

By Product Type

  • Software-Based Solutions
  • Hardware-Based Solutions

By Application

  • Stroke Rehabilitation
  • Traumatic Brain Injury (TBI) Rehabilitation
  • Neurodegenerative Disorders
  • Learning and Memory Enhancement
  • Mental Health Disorders

By End User

  • Hospitals and Clinics
  • Research Institutes and Academic Centers
  • Pharmaceutical and Biotechnology Companies
  • Others

By Region

  • Europe
  • North America
  • Asia Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of the region will also be provided in the final version of this market, which is based on the conclusion of primary interviews and secondary data points gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022 due to the increasing prevalence of neurological disorders in the region, such as Alzheimer's disease, Parkinson's disease, and stroke. Additionally, the growing awareness of neuroplasticity and its potential benefits is driving North America's market growth. Conversely, the European region is poised for substantial expansion in the forecast period due to the region's well-established healthcare infrastructure, which supports the development and adoption of neuroplasticity therapies. The increasing government funding for research in neuroplasticity is also driving market growth in Europe.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Neuroplasticity Market By Product Type, By Application, By End User, and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape, mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.  Market Introduction
    •   1. Objectives of the Study 
        2. Market Definition 
        3. Market Scope 
           3.1. Years Considered for the Study
           3.2. Market Covered
        4. Currency 
        5. Limitations 
        6. Stakeholders 

  • 2.  Research Methodology
    •   1. Research Data 
           1.1. Secondary Data
              1.1.1. Key Data from Secondary Sources
           1.2. Primary Data
              1.2.1. Key Data from Primary Sources
        3. Market Size Estimation 
        4. Market Breakdown and Data Triangulation 
        5. Assumptions for the Study 

  • 3.  Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights

  • 4.  Neuroplasticity Market Variables, Trends & Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Application Overview
        6. Regulatory Framework
           6.1. Reimbursement Framework
           6.2. Standards and Compliances

  • 5.  Market Overview
    •   1. Market Dynamics
           1.1. Market Driver Analysis
              1.1.1. Increasing focus of Neuroplasticity Market Companies on Brand Protection
              1.1.2. Untapped Opportunities in Emerging Regions
           1.2. Market Restraint Analysis
              1.2.1. High Cost Associated with Implementation of Predictive Analysis
           1.3. Industry Challenges
              1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.  Neuroplasticity Market Analysis Tools
    •   1. Industry Analysis - Porter’s
           1.1. Supplier Power
           1.2. Buyer Power
           1.3. Substitution Threat
           1.4. Threat from New Entrants
           1.5. Competitive Rivalry
        2. Pestel Analysis
           2.1. Political Landscape
           2.2. Environmental Landscape
           2.3. Social Landscape
           2.4. Application Landscape
           2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
           3.1. Joint Ventures
           3.2. Mergers and Acquisitions
           3.3. Licensing and Partnership
           3.4. Application Collaborations
           3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.  Neuroplasticity Market, By Product Type Historical Analysis and Forecast 2024-2032 (USD Million)
      1. Software-Based Solutions
      2. Hardware-Based Solutions
  • 8.  Neuroplasticity Market, By Application Historical Analysis and Forecast 2024-2032 (USD Million)
      1. Stroke Rehabilitation
      2. Traumatic Brain Injury (TBI) Rehabilitation
      3. Neurodegenerative Disorders
      4. Learning and Memory Enhancement
      5. Mental Health Disorders
  • 9.  Neuroplasticity Market, By End User Historical Analysis and Forecast 2024-2032 (USD Million)
      1. Hospitals and Clinics
      2. Research Institutes and Academic Centers
      3. Pharmaceutical and Biotechnology Companies
      4. Others
  • 10.  North America Neuroplasticity Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. U.S.A
           2.2. Canada
           2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2024-2032

  • 11.  Latin America Neuroplasticity Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Brazil
           2.2. Venezuela
           2.3. Argentina
           2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2024-2032

  • 12.  Europe Neuroplasticity Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Germany
           2.2. U.K
           2.3. France
           2.4. Italy
           2.5. Spain
           2.6. Russia
           2.7. Poland
           2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2024-2032

  • 13.  Asia Pacific Neuroplasticity Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Japan
           2.2. China
           2.3. India
           2.4. Australia and New Zealand
           2.5. ASEAN
           2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2024-2032  

  • 14.  Middle East and Africa Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. GCC
           2.2. Israel
           2.3. South Africa
           2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2024-2032

  • 15.  Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 16.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. NeuroSky Inc.
           1.1. Company Overview
           1.2. Product Portfolio
           1.3. SWOT Analysis
           1.4. Financial Overview
           1.5. Strategic Overview
        2. Posit Science Corporation
           2.1. Company Overview
           2.2. Product Portfolio
           2.3. SWOT Analysis
           2.4. Financial Overview
           2.5. Strategic Overview
        3. BrainHQ
           3.1. Company Overview
           3.2. Product Portfolio
           3.3. SWOT Analysis
           3.4. Financial Overview
           3.5. Strategic Overview
        4. Synaptitude Brain Health
           4.1. Company Overview
           4.2. Product Portfolio
           4.3. SWOT Analysis
           4.4. Financial Overview
           4.5. Strategic Overview
        5. Mindmaze SA
           5.1. Company Overview
           5.2. Product Portfolio
           5.3. SWOT Analysis
           5.4. Financial Overview
           5.5. Strategic Overview
        6. NeuroVigil Inc.
           6.1. Company Overview
           6.2. Product Portfolio
           6.3. SWOT Analysis
           6.4. Financial Overview
           6.5. Strategic Overview
        7. Lumosity
           7.1. Company Overview
           7.2. Product Portfolio
           7.3. SWOT Analysis
           7.4. Financial Overview
           7.5. Strategic Overview
        8. Neuronetics, Inc.
           8.1. Company Overview
           8.2. Product Portfolio
           8.3. SWOT Analysis
           8.4. Financial Overview
           8.5. Strategic Overview
        9. CogniFit
           9.1. Company Overview
           9.2. Product Portfolio
           9.3. SWOT Analysis
           9.4. Financial Overview
           9.5. Strategic Overview
        10. Advanced Brain Monitoring
           10.1. Company Overview
           10.2. Product Portfolio
           10.3. SWOT Analysis
           10.4. Financial Overview
           10.5. Strategic Overview
        11. SharpBrains
           11.1. Company Overview
           11.2. Product Portfolio
           11.3. SWOT Analysis
           11.4. Financial Overview
           11.5. Strategic Overview
        12. Emotiv Inc.
           12.1. Company Overview
           12.2. Product Portfolio
           12.3. SWOT Analysis
           12.4. Financial Overview
           12.5. Strategic Overview
        13. BrainCo
           13.1. Company Overview
           13.2. Product Portfolio
           13.3. SWOT Analysis
           13.4. Financial Overview
           13.5. Strategic Overview
        14. Neuroscape
           14.1. Company Overview
           14.2. Product Portfolio
           14.3. SWOT Analysis
           14.4. Financial Overview
           14.5. Strategic Overview
        15. Neuroplast BV
           15.1. Company Overview
           15.2. Product Portfolio
           15.3. SWOT Analysis
           15.4. Financial Overview
           15.5. Strategic Overview
        16. Reha Technology AG
           16.1. Company Overview
           16.2. Product Portfolio
           16.3. SWOT Analysis
           16.4. Financial Overview
           16.5. Strategic Overview
        17. Virtualware Group
           17.1. Company Overview
           17.2. Product Portfolio
           17.3. SWOT Analysis
           17.4. Financial Overview
           17.5. Strategic Overview
        18. Nexeon Medsystems Inc.
           18.1. Company Overview
           18.2. Product Portfolio
           18.3. SWOT Analysis
           18.4. Financial Overview
           18.5. Strategic Overview

  • 17.  Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated
      by administrations
        5. The overall economic slowdown of the developing and developed nations

  • 18.  FutureWise SME Key Takeaway Points for Client
    •   

Partner

Our Clients